Journal of Vascular and Endovascular Therapy

Description

An aortic aneurysm is a serious medical condition where a portion of the aorta the largest artery in the body becomes abnormally enlarged due to a weakening of its walls. If left untreated an aneurysm can rupture, causing life-threatening internal bleeding. Aortic aneurysm repair is a critical procedure aimed at preventing rupture by reinforcing or replacing the weakened section of the aorta [1]. This article the types indications techniques benefits risks and advancements in aortic aneurysm repair. The aorta carries oxygen rich blood from the heart to the rest of the body. An aneurysm can occur anywhere along the aorta but is most commonly seen in the abdominal section abdominal aortic aneurysm or the chest thoracic aortic aneurysm. Conditions such as hypertension atherosclerosis genetic disorders and smoking increase the risk of developing an aortic aneurysm. Aging and a family history of aneurysms also contribute to the likelihood of occurrence [2]. Small aneurysms often cause no symptoms. As they grow they may cause back or abdominal pain a pulsating sensation in the abdomen or chest pain in the case of thoracic aneurysms. Large aneurysms pose a high risk of rupture which can lead to sudden and severe symptoms, including shock. The traditional method involves a large abdominal or chest incision to access the aorta. The damaged section is replaced with a synthetic graft. Long term durability suitable for complex cases. Longer recovery time more invasive and higher risk of complications in elderly or high risk patients. A minimally invasive technique where a stent graft is delivered to the aneurysm site through small incisions in the groin. Reduced recovery time less invasive and fewer complications. Requires regular follow up imaging to ensure graft stability not suitable for all aneurysm anatomies. Detailed imaging, such as angiography or is performed to determine the size location complications. Recovery times vary requires weeks to months while patients often resume normal activities within days [3]. The primary benefit of aortic aneurysm repair is preventing rupture which is often fatal.

Complications

Relief of symptoms such as pain or a pulsating sensation. Improved quality of life by reducing the risk of emergency medical events. Infection at the surgical site or within the graft. Kidney damage due to impaired blood flow during surgery or contrast dye used in imaging. End leaks blood continues to flow into the aneurysm sac requiring additional intervention [4]. Heart or lung complications especially in patients with preexisting conditions. Advancements in aortic aneurysm repair continuous innovation in surgical techniques and devices has improved outcomes for patients undergoing aortic aneurysm repair. Next generation stent grafts custom made devices for patients with challenging anatomies [5]. Hybrid approaches combining open and endovascular techniques to manage complex aneurysms. Improved imaging technology enhancing procedural accuracy and monitoring post repair stability. Artificial intelligence assisting in risk assessment and procedural planning. While repair is for large or symptomatic aneurysms, prevention strategies focus on managing risk factors [6]. Regular monitoring through imaging for small aneurysms. Controlling blood pressure and cholesterol levels. Quitting smoking to reduce aneurysm growth rate. Hypersensitivity Regular checkups for individuals with a family history of aneurysms. Aortic aneurysm repair is a lifesaving procedure that has evolved significantly over the years. With options ranging from traditional open surgery to minimally invasive the approach is customized the patient's condition and anatomy [7]. Advances in technology and techniques continue to improve patient outcomes reducing the risks and recovery times associated with this critical intervention. Early detection and timely treatment remain key to managing aortic aneurysms effectively underscoring the importance of regular medical evaluations and lifestyle modifications to mitigate risk factors. High blood pressure atherosclerosis smoking, aging and genetic conditions like marfa syndrome contribute to aneurysm development.

Hypersensitivity

Regular checkups for individuals with a family history of aneurysms. Aortic aneurysm repair is a lifesaving procedure that has evolved significantly over the years [8]. With options ranging from traditional open surgery to minimally invasive the approach is customized to the patient's condition and anatomy. Advances in technology and techniques continue to improve patient outcomes, reducing the risks and recovery times associated with this critical intervention [9]. Early detection and timely treatment remain key to managing aortic aneurysms effectively, underscoring the importance of regular medical evaluations and lifestyle modifications to mitigate risk factors [10].

High blood pressure, atherosclerosis, smoking, aging and genetic conditions like Marfa syndrome contribute to aneurysm development

References

1. Yang M, Wu Y, Liu X, Zhao C, Li T, et al. (2023) Efficacy and safety of antifibrotic agents in the treatment of CTD-ILD and RA-ILD: A systematic review and meta-analysis. Respir Med 216: 107329.

   [Crossref], [Google Scholar], [Indexed]

2. Cottin V (2019) Treatment of progressive fibrosing interstitial lung diseases: A milestone in the management of interstitial lung diseases. Eur Respir Rev 28: 190109.

   [Crossref], [Google Scholar], [Indexed]

3. Liu GY, Budinger GRS, Dematte JE (2022) Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. BMJ 377: e066354.

   [Crossref], [Google Scholar], [Indexed]

4. Juge PA, Borie R, Kannengiesser C, Gazal S, Revy P, et al. (2017) Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis. Eur Respir J 49: 1602314.

   [Crossref], [Google Scholar], [Indexed]

5. Ley B, Newton CA, Arnould I, Henry T, Vittinghoff E, et al. (2017) The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: An observational cohort-control study. Lancet Respir Med 5: 639-647.

   [Crossref], [Google Scholar], [Indexed]

6. Oldham JM, Adegunsoye A, Valenzi E, Lee C, Witt L, et al. (2016) Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J 47: 1767-1775.

   [Crossref], [Google Scholar], [Indexed]

7. Khanna D, Tashkin DP, Denton CP, Renzoni EA, Desai SR, et al. (2020) Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease. Am J Respir Crit Care Med 201: 650-660.

   [Crossref], [Google Scholar], [Indexed]

8. Ko UW, Cho EJ, Oh HB, Koo HJ, Do KH, et al. (2020) Serum Krebs von den lungen-6 level predicts disease progression in interstitial lung disease. PLoS One 15: e0244114.

   [Crossref], [Google Scholar], [Indexed]

9. Birch J, Barnes PJ, Passos JF (2018) Mitochondria, telomeres and cell senescence: Implications for lung ageing and disease. Pharmacol Ther 183: 34-49.

   [Crossref], [Google Scholar], [Indexed]

10. Lee JS, La J, Aziz S, Dobrinskikh E, Brownel R, et al. (2021) Molecular markers of telomere dysfunction and senescence are common findings in the usual interstitial pneumonia pattern of lung fibrosis. Histopathology 79: 67-76.

    [Crossref], [Google Scholar], [Indexed]